IMCAS Asia 2025
Program

Objectives: This session explores the capabilities of the Fotona PQX Picosecond Laser beyond traditional pigmentation treatments, focusing specifically on maximizing its pico energy potential to effectively address skin rejuvenation concerns, including texture, fine lines, and pores.

Introduction: Picosecond lasers are well-known for treating pigmentation and clearing tattoos, but their role may extend further into skin rejuvenation. Fotona PQX features high peak power and dual handpieces—full-beam and fractional—designed to effectively target both superficial and deeper skin layers, reaching depths of up to 3 mm. This combination enables comprehensive improvement in skin texture, fine lines, pores, and overall skin quality, suggesting broader applications beyond pigmentation treatment alone.

Materials / method: This study included 10 Asian patients with Fitzpatrick skin types III–V, presenting with varying signs of skin aging features such as texture irregularities, enlarged pores, and fine lines. Each participant underwent five sessions of Fotona PQX treatment at 3-week intervals.

Results: VISIA analysis at 4 weeks after the final treatment showed visible improvement in overall skin quality, including texture, fine lines, and pore appearance across all participants. Mild adverse effects such as transient erythema, petechiae, and pruritus were observed in some patients, all resolving within 7 days. No severe or permanent complications were reported.

Conclusion: The Fotona PQX picosecond laser demonstrated promising results beyond pigmentation and tattoos, showing improvements in skin texture, fine lines, and pores. With a favorable safety profile and no long-term adverse effects, it offers an effective and well-tolerated option for comprehensive skin rejuvenation.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): Fotona

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Fotona

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Fotona